Content that has been automatically archived
FDA Withdraws Exceptions for Laboratory-Developed COVID-19 Tests
The Food & Drug Administration (FDA) has reversed the prior administration’s policy on pre-market review exception for COVID-19 laboratory-developed tests that allowed the tests to be offered prior to or without FDA authorization.